Hangzhou Coco Healthcare Products Co.,Ltd. (SHE:301009)
China · Delayed Price · Currency is CNY 13.41
+0.02 (0.15%)
At close: Feb 6, 2026
SHE:301009 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 37.09 | 31.17 | 20.18 | -43.13 | 39.75 | 214.01 |
Depreciation & Amortization | 58.18 | 58.18 | 56.84 | 61.25 | 49.43 | 39.24 |
Other Amortization | 4.99 | 4.99 | 4.78 | 5.53 | 5.34 | 2.65 |
Loss (Gain) From Sale of Assets | 0.04 | 0.04 | 0.1 | -0.12 | -0.04 | 0.01 |
Asset Writedown & Restructuring Costs | 0.21 | 0.21 | 13.86 | 62.3 | 0.16 | 39.54 |
Loss (Gain) From Sale of Investments | 0.38 | 0.38 | 3.34 | -0.24 | -5.05 | -1.11 |
Provision & Write-off of Bad Debts | 0.84 | 0.84 | -3.48 | 5.21 | -2.07 | - |
Other Operating Activities | 51.14 | 5.31 | 2.08 | -17.27 | 16.79 | 33.84 |
Change in Accounts Receivable | -44.84 | -44.84 | 55.6 | -30.95 | 114.13 | -101.19 |
Change in Inventory | -39.46 | -39.46 | 57.89 | -40.23 | -34.04 | 4.46 |
Change in Accounts Payable | 36.94 | 36.94 | 18.38 | -33.46 | -137.69 | 167.6 |
Change in Other Net Operating Assets | - | - | - | - | - | 0.4 |
Operating Cash Flow | 104.19 | 52.44 | 227.7 | -37.2 | 50.53 | 395.86 |
Operating Cash Flow Growth | 0.42% | -76.97% | - | - | -87.24% | 77.26% |
Capital Expenditures | -40.76 | -75.35 | -66.01 | -116.4 | -240.45 | -220.71 |
Sale of Property, Plant & Equipment | -1.54 | 4.44 | 0.69 | 0.61 | 0.47 | 0.12 |
Investment in Securities | -77 | -260 | -10.56 | - | 120 | -100.25 |
Other Investing Activities | 6.15 | 2.44 | 2.64 | 3.65 | 5.06 | 9.37 |
Investing Cash Flow | -113.15 | -328.47 | -73.25 | -112.14 | -114.92 | -311.47 |
Short-Term Debt Issued | - | 100.01 | 3.05 | - | 50 | 138.9 |
Total Debt Issued | 349.32 | 100.01 | 3.05 | - | 50 | 138.9 |
Short-Term Debt Repaid | - | - | - | - | -149.1 | -80.6 |
Long-Term Debt Repaid | - | -4.26 | -2.76 | -0.84 | -2.25 | - |
Total Debt Repaid | -154.68 | -4.26 | -2.76 | -0.84 | -151.35 | -80.6 |
Net Debt Issued (Repaid) | 194.63 | 95.74 | 0.3 | -0.84 | -101.35 | 58.3 |
Issuance of Common Stock | - | - | - | - | 761.55 | - |
Repurchase of Common Stock | -49.69 | -49.69 | - | - | - | - |
Common Dividends Paid | -18.74 | -20.14 | - | -19.03 | -0.88 | -23.63 |
Other Financing Activities | 61.8 | 1.16 | 0.1 | -30 | 24.5 | -6.2 |
Financing Cash Flow | 188 | 27.07 | 0.4 | -49.87 | 683.82 | 28.47 |
Foreign Exchange Rate Adjustments | 2.75 | 6.21 | 2.14 | 4.24 | -2.65 | -11.65 |
Net Cash Flow | 181.8 | -242.75 | 156.99 | -194.97 | 616.78 | 101.21 |
Free Cash Flow | 63.42 | -22.91 | 161.69 | -153.6 | -189.92 | 175.15 |
Free Cash Flow Growth | 143.47% | - | - | - | - | 79.71% |
Free Cash Flow Margin | 5.67% | -2.12% | 14.95% | -12.95% | -16.01% | 10.71% |
Free Cash Flow Per Share | 0.25 | -0.09 | 0.56 | -0.57 | -0.81 | 0.86 |
Cash Income Tax Paid | - | -25.17 | -12.13 | -60.14 | -10.59 | -27.86 |
Levered Free Cash Flow | 35.14 | -34.57 | 134.51 | -266.81 | -285.95 | 105.74 |
Unlevered Free Cash Flow | 36.24 | -34.12 | 134.92 | -266.64 | -285.35 | 107.07 |
Change in Working Capital | -48.67 | -48.67 | 129.99 | -110.75 | -53.78 | 67.67 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.